203 related articles for article (PubMed ID: 11881121)
1. No effect of angiotensin II AT(2)-receptor antagonist PD 123319 on cerebral blood flow autoregulation.
Estrup TM; Paulson OB; Strandgaard S
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):188-92. PubMed ID: 11881121
[TBL] [Abstract][Full Text] [Related]
2. Nonpeptide angiotensin AT1 and AT2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats.
Strömberg C; Näveri L; Saavedra JM
J Cereb Blood Flow Metab; 1993 Mar; 13(2):298-303. PubMed ID: 8436622
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II AT2 receptor stimulation extends the upper limit of cerebral blood flow autoregulation: agonist effects of CGP 42112 and PD 123319.
Näveri L; Strömberg C; Saavedra JM
J Cereb Blood Flow Metab; 1994 Jan; 14(1):38-44. PubMed ID: 8263056
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation.
Vraamark T; Waldemar G; Strandgaard S; Paulson OB
J Hypertens; 1995 Jul; 13(7):755-61. PubMed ID: 7594439
[TBL] [Abstract][Full Text] [Related]
5. The role of angiotensin receptor subtypes in cerebrovascular regulation in the rat.
Näveri L
Acta Physiol Scand Suppl; 1995; 630():1-48. PubMed ID: 8610501
[TBL] [Abstract][Full Text] [Related]
6. Cerebral blood flow (CBF) autoregulation in spontaneously hypertensive rats (SHR) during chronic administration of a theophylline derivative (P-23).
Kozłowska T; Olejnik A; Krawczak J; Chodera A; Barry D; Pedersen E
Pol J Pharmacol Pharm; 1989; 41(6):611-8. PubMed ID: 2518576
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme inhibition and cerebral blood flow autoregulation in normotensive and hypertensive man.
Waldemar G; Schmidt JF; Andersen AR; Vorstrup S; Ibsen H; Paulson OB
J Hypertens; 1989 Mar; 7(3):229-35. PubMed ID: 2540235
[TBL] [Abstract][Full Text] [Related]
8. Converting enzyme inhibition and autoregulation of cerebral blood flow in spontaneously hypertensive and normotensive rats.
Strandgaard S; Barry DI; Paulson OB
Scand J Urol Nephrol Suppl; 1984; 79():35-8. PubMed ID: 6089316
[TBL] [Abstract][Full Text] [Related]
9. Acute sympathetic denervation does not eliminate the effect of angiotensin converting enzyme inhibition on CBF autoregulation in spontaneously hypertensive rats.
Waldemar G
J Cereb Blood Flow Metab; 1990 Jan; 10(1):43-7. PubMed ID: 2404998
[TBL] [Abstract][Full Text] [Related]
10. Valsartan improves the lower limit of cerebral autoregulation in rats.
Takada J; Ibayashi S; Ooboshi H; Ago T; Ishikawa E; Kamouchi M; Kitazono T; Iida M
Hypertens Res; 2006 Aug; 29(8):621-6. PubMed ID: 17137218
[TBL] [Abstract][Full Text] [Related]
11. Ceranapril and cerebral blood flow autoregulation.
Torup M; Waldemar G; Paulson OB
J Hypertens; 1993 Apr; 11(4):399-405. PubMed ID: 8390507
[TBL] [Abstract][Full Text] [Related]
12. Cerebrovascular effects of the converting enzyme inhibitor captopril.
Jarden JO; Barry DI; Strandgaard S; Graham DI; Paulson OB
J Hypertens Suppl; 1983 Dec; 1(2):126-8. PubMed ID: 6400112
[TBL] [Abstract][Full Text] [Related]
13. Captopril treatment temporarily restores cerebral blood flow autoregulation in spontaneously hypertensive rats after hemorrhagic stroke.
Davis LA; Smeda JS
J Cardiovasc Pharmacol; 2010 Sep; 56(3):255-62. PubMed ID: 20531216
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors.
Ognibene DT; Oliveira PR; Marins de Carvalho LC; Costa CA; Espinoza LA; Criddle DN; Tano T; Soares de Moura R; Resende AC
Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):12-9. PubMed ID: 18986337
[TBL] [Abstract][Full Text] [Related]
15. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
16. [Effects of alpha- and beta-adrenergic blockers on the lower limits of cerebral blood flow autoregulation in spontaneously hypertensive rats].
Sadoshima S; Okada Y; Ooboshi H; Shiokawa O; Fujishima M
Fukuoka Igaku Zasshi; 1990 May; 81(5):204-8. PubMed ID: 1974240
[TBL] [Abstract][Full Text] [Related]
17. Converting enzyme inhibition resets cerebral autoregulation at lower blood pressure.
Paulson OB; Vorstrup S; Andersen AR; Smith J; Godtfredsen J
J Hypertens Suppl; 1985 Dec; 3(3):S487-8. PubMed ID: 2856774
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibition and the upper limit of cerebral blood flow autoregulation: effect of sympathetic stimulation.
Waldemar G; Paulson OB; Barry DI; Knudsen GM
Circ Res; 1989 Jun; 64(6):1197-204. PubMed ID: 2655965
[TBL] [Abstract][Full Text] [Related]
19. Functional interaction of AT1 and AT2 receptors in fructose-induced insulin resistance and hypertension in rats.
Hsieh PS; Tai YH; Loh CH; Shih KC; Cheng WT; Chu CH
Metabolism; 2005 Feb; 54(2):157-64. PubMed ID: 15690308
[TBL] [Abstract][Full Text] [Related]
20. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
